Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide
Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.
Engineered to meet unique automation needs across various industries, Epson Robots, the #1 SCARA robot manufacturer in the world, today announced the new GX Series robot lineup with the GX4 and GX8.
BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announced today that is has received Good Manufacturing Practice (GMP) approval from the Israel Ministry of Health for three state-of-the-art cleanrooms…
WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has received the License of Manufacturing Permit from German health authorities for its drug product facility (DP7) in Leverkusen, Germany. The permit successfully demonstrates for the first time that Premier Quality together with Record Speed WuXi Biologics consistently delivered in China can also be applied in global countries.
Quattroflow, part of PSG and Dover (NYSE: DOV), announced that it will increase manufacturing capacity for its single-use quaternary diaphragm pumps with the construction of a new ISO Class 7 cleanroom.
Expected to open in October 2021, the additional cleanroom will more than double the Quattroflow cleanroom space in Duisburg, Germany.
As New York City begins its early phases of reopening since the onset of the pandemic, cleanroom design and construction services firm Precision Cleanrooms makes its claim in the Big Apple with its first New York City office in the company’s 32-year history. Located in Union Square at 41 East 11th Street, Precision Cleanrooms’ New York office will serve customers in greater New York and the extended Northeastern United States, providing turnkey cleanroom solutions and services for many industries including: pharmaceutical, biotech, medical device, and microelectronics industries.
PAJUNK, a leading global provider of medical devices, moved into its new headquarters, located in Alpharetta, GA, just north of Atlanta. The 50,000 square foot building houses new office space, a state-of-the-art clean room for manufacturing procedural trays, and a 30,000 square foot warehouse. The increased space is designed to keep up with growing demands while providing best-in-class customer service.
Novo Holdings today announced that it has co-led with Vivo Capital the over-subscribed US$200 million Series A and Crossover round in Esco Lifesciences Group (“Esco”), a leading provider of life sciences tools and services. The financing will enable Esco to strengthen its position through organic and external growth and transformation, as well as invest in China, thus addressing some of the most dynamic market segments and geographies. Other investors include two Asian sovereign wealth funds and Singapore-based global investor, EDBI.
Novatek Requalified as an approved supplier for Boehringer Ingelheim, a global leader in healthcare. Novatek regulatory compliant quality solutions is used at Boehringer Ingelheim for its human pharma, animal health and biopharmaceutical aseptic (sterile) manufacturing sites worldwide.
Freudenberg Medical, a global contract design and manufacturing provider to the medical device industry, is expanding its manufacturing operations in Alajuela, Costa Rica. The expansion project adds 8,600 square feet to the existing facility which includes construction of an additional ISO Class 7 cleanroom for catheter manufacturing and assembly, molding, extrusion, and packaging, as well as added office space. New technology includes an advanced thermoplastic extrusion line which can produce tubing from 4 inches to 170 inches long with capacity of up to 1 million parts per month, plus additional injection molding machines.
Prenetics Limited, a global leader in diagnostics and genetic testing, Oxford University and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed multi-million dollar collaboration agreements to further develop the award-winning OxLAMP™ technology, a rapid, molecular testing technology for infectious diseases.